decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Medicare_Carriers_Manual / 5202 / 5202
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare payment-limit policy for selected drugs and biologicals and identifies broad categories of items that may fall under that policy. It is relevant to providers, billing staff, pharmacy-related claims teams, and coders who work with Medicare reimbursement guidance for drugs and biologics.
Why This Topic Matters
Understanding this manual section helps readers recognize where Medicare payment limits apply and why documentation and billing processes for affected drugs and biologicals need careful attention.
Article Sections
-
5202. Payment Limit for Certain Drugs and Biologicals
Covers the Medicare payment-limit framework for certain drugs and biologicals and notes the kinds of published pricing sources referenced by the manual. It also identifies general categories of drugs and biologics discussed under this policy.
What You Will Learn
- The scope of the Medicare payment-limit policy for certain drugs and biologicals
- Which general categories of drugs and biologicals are discussed in relation to the policy
- The type of pricing references used in the payment-limit discussion
- How the article is organized within the Medicare Carriers Manual
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Pharmacy claims personnel
- Compliance staff
- Provider offices
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com